MorphoSys AG / MorphoSys to Present Data on Proprietary Programs at American Society of Hematology Annual Meeting . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Abstracts Include Preliminary Safety and Efficacy Data for MOR208 in NHL





List of All Abstracts:

A Phase IIa, Open-Label, Multicenter Study of Single-Agent MOR00208, an Fc-Optimized Anti-CD19 Antibody, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma:
http://bit.ly/1y8GpNm

Final Results and Follow-up of a Phase I Study of the Fc Engineered CD19 Antibody XmAb®5574 (aka MOR00208) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL):
http://bit.ly/1y8GSiv




www.hematology.org/Meetings/Annual-Meeting and http://bloodjournal.hematologylibrary.org/:
http://www.hematology.org/Meetings/Annual-Meeting

http://www.bloodjournal.org/content/early/2014/10/09/blood-2014-08-593269 :
http://www.bloodjournal.org/content/early/2014/10/09/blood-2014-08-593269

About MorphoSys:

pipeline :
http://www.morphosys.com/pipeline








For more information, please contact:
















Media Release (PDF):
http://hugin.info/130295/R/1869280/657224.pdf


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: MorphoSys AG via Globenewswire
HUG#1869280

--- End of Message ---

MorphoSys AG
Lena-Christ-Str. 48 Martinsried / Munich Germany

WKN: 663200;ISIN: DE0006632003;Index:TecDAX,CDAX,Prime All Share,TECH All Share,HDAX,MIDCAP;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;